Literature DB >> 1906886

The effect of glycoprotein IIb-IIIa receptor occupancy on the cytoskeleton of resting and activated platelets.

W C Kouns1, C F Fox, W J Lamoreaux, L B Coons, L K Jennings.   

Abstract

The platelet integrin, glycoprotein IIb-IIIa (GPIIb-IIIa), serves as the receptor for fibrinogen. This study examined what effect GPIIb-IIIa receptor occupancy had on the cytoskeleton of resting and activated platelets. Triton X-100-insoluble residues (cytoskeletons) were isolated from resting washed platelets incubated with either 500 microM RGDS or 500 microM RGES and examined for protein content. RGDS did not increase the amount of GPIIb-IIIa associated with the cytoskeletal residues which sedimented at either 15,800 x g or 100,000 x g. To determine the effect of receptor occupancy on the formation of the activated platelet cytoskeleton, stirred and nonstirred RGDS-treated platelets in plasma were activated with ADP. Triton X-100-insoluble residues were isolated and examined for both protein content and retention of GPIIb-IIIa. Further, morphological studies were performed on the RGDS-ADP-stimulated platelets. The results of this study suggest that 1) RGDS peptide receptor occupancy does not lead to GPIIb-IIIa linkage to the cytoskeleton, 2) ADP-stimulated platelet shape change, polymerization of actin, and association of myosin with the cytoskeleton are unaffected by RGDS peptide receptor occupancy. 3) RGDS inhibits an aggregation-dependent incorporation of ABP, alpha-actinin, talin, and GPIIb-IIIa into the Triton-insoluble residue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906886

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Disaggregation of aggregated platelets by savignygrin, a alphaIIbeta3 antagonist from Ornithodoros savignyi.

Authors:  Ben J Mans; Abraham I Louw; Albert W H Neitz
Journal:  Exp Appl Acarol       Date:  2002       Impact factor: 2.132

Review 2.  Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

Authors:  H Benjamin Starnes; Ankit A Patel; George A Stouffer
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

3.  Integrin-dependent translocation of p160ROCK to cytoskeletal complex in thrombin-stimulated human platelets.

Authors:  A Fujita; Y Saito; T Ishizaki; M Maekawa; K Fujisawa; F Ushikubi; S Narumiya
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

4.  Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation.

Authors:  M Torti; G Ramaschi; F Sinigaglia; E G Lapetina; C Balduini
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

5.  Proteolytic degradation of the RGD-binding and non-RGD-binding conformers of human platelet integrin glycoprotein IIb/IIIa: clues for identification of regions involved in the receptor's activation.

Authors:  J J Calvete; K Mann; W Schäfer; R Fernandez-Lafuente; J M Guisán
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

6.  Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase.

Authors:  M Chellaiah; K Hruska
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

7.  Site-specific phosphorylation of kindlin-3 protein regulates its capacity to control cellular responses mediated by integrin αIIbβ3.

Authors:  Katarzyna Bialkowska; Tatiana V Byzova; Edward F Plow
Journal:  J Biol Chem       Date:  2015-01-21       Impact factor: 5.157

8.  Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures.

Authors:  K M Pumiglia; M B Feinstein
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

9.  Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.

Authors:  M Torti; G Ramaschi; F Sinigaglia; E G Lapetina; C Balduini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution.

Authors:  P J Newman; C A Hillery; R Albrecht; L V Parise; M C Berndt; A V Mazurov; L C Dunlop; J Zhang; S E Rittenhouse
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.